Abstract:Background: Preeclampsia (PE) is a hypertensive pregnancy disorder linked to placental dysfunction, often involving pathological lesions like acute atherosis, decidual vasculopathy, accelerated villous maturation, and fibrinoid deposition. However, there is no gold standard for the pathological diagnosis of PE and this limits the ability of clinicians to distinguish between PE and non-PE pregnancies. Recent advances in computational pathology have provided the opportunity to automate pathological analysis for diagnosis, classification, prediction, and prediction of disease progression. In this study, we assessed whether computational pathology could be used to identify PE placentas. Methods: A total of 168 placental whole-slide images (WSIs) of patients from Seoul National University Hospital (comprising 84 PE cases and 84 normal controls) were used for model development and internal validation. For external validation of the model, 76 placental slides (including 38 PE cases and 38 normal controls) were obtained from the Boramae Medical Center (BMC). To establish standard criteria for diagnosing PE and distinguishing it from controls using placental WSIs, patch characteristics and quantification of terminal and intermediate villi were employed. In unsupervised learning, K-means clustering was conducted as a feature obtained through an Auto Encoder to extract the ratio of each cluster for each WSI. For supervised learning, quantitative assessments of the villi were obtained using a U-Net-based segmentation algorithm. The prediction model was developed using an ensemble method and was compared with a clinical feature model developed by using placental size features. Results: Using ensemble modeling, we developed a model to identify PE placentas. The model showed good performance (area under the precision-recall curve [AUPRC], 0.771; 95% confidence interval [CI], 0.752-0.790), with 77.3% of sensitivity and 71.1% of specificity, whereas the clinical feature model showed an AUPRC 0.713 (95% CI, 0.694-0.732) with 55.6% sensitivity and 86.8% specificity. External validation of the predictive model employing the BMC-derived set of placental slides also showed good discrimination (AUPRC, 0.725; 95% CI, 0.720-0.730). Conclusion: The proposed computational pathology model demonstrated a strong ability to identify preeclamptic placentas. Computational pathology has the potential to improve the identification of PE placentas.

Quantifying Molecular Changes in the Preeclamptic Rat Placenta with Targeted Contrast-Enhanced Ultrasound Imaging

Ultrasound based radiomics model for assessment of placental function in pregnancies with preeclampsia

Modeling Normal Mouse Uterine Contraction and Placental Perfusion with Non-invasive Longitudinal Dynamic Contrast Enhancement MRI

Human placental perfusion measured using dynamic contrast enhancement MRI

Ultrasound-based Radiomics Model: a Potential Adjunctive Tool for Assessing Impaired Placental Function in Preeclampsia

Radiomics Analysis of Placenta on T2WI Facilitates Prediction of Postpartum Haemorrhage: A Multicentre Study.

Ferumoxytol dynamic contrast enhanced magnetic resonance imaging identifies altered placental cotyledon perfusion in rhesus macaques

Assessment of feto-placental oxygenation and perfusion in a rat model of placental insufficiency using T2* mapping and 3D dynamic contrast-enhanced MRI

Dynamic contrast enhanced MRI demonstrate altered placental perfusion in the STOX1A preeclampsia mouse model

Preeclampsia associated changes in volume density of fetoplacental vessels in Chinese women and mouse model of preeclampsia

In Vivo Assessment of the Placental Anatomy and Perfusion in a Mouse Model of Intrauterine Inflammation.

Placental multimodal MRI prior to spontaneous preterm birth <32 weeks' gestation: An observational study

A study of monitoring risk of preeclampsia pregnant women using three-dimensional color power Doppler ultrasound and u-maspin gene of maternal plasma

Comparative peptidomics analysis of preeclamptic placenta and the identification of a novel bioactive SERPINA1 C-terminal peptide

A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia

Dynamic glucose enhanced MRI of the placenta in a mouse model of intrauterine inflammation

Alteration of vascularization in preeclamptic placentas measured by three-dimensional power Doppler ultrasound

Identification of Preeclamptic Placenta in Whole Slide Images Using Artificial Intelligence Placenta Analysis

Serial evaluation of morphological and biophysical placental attributes in women with normal outcome and preeclampsia

Ex vivo magnetic resonance angiography to explore placental vascular anatomy

Identifying placental metabolic biomarkers of preterm birth using nuclear magnetic resonance of intact tissue samples